DPhil research opportunities 2023
The deadline for applications for any Oxford-administered scholarships, including the RDM Scholars Programme and the WIMM Prize Studentship, has now passed. We continue to accept applications for unfunded places and prospective applicants should contact their prospective supervisor in advance of making an application to ensure availability of research opportunities. We advise you to submit your application as soon as possible. This allows more time to complete all admissions processes and makes it easier to find a college place. You should be aware that applications received before the funding deadline of 9 December will be processed prior to any later applications being considered. The latest date you can apply for a place for October 2023 entry is 30 June, 2023.
| Title | |
|---|---|
| Antanaviciute Group - Computational biology and machine learning for characterising spatial tissue niches and cellular signalling across space and time of human immune system development Antanaviciute Group - Computational biology and machine learning for characterising spatial tissue niches and cellular signalling across space and time of human immune system development | Agne Antanaviciute |
| Koohy Group - Applications of multi-omics and AI to better understand T cell immunity and antigen-specificity Koohy Group - Applications of multi-omics and AI to better understand T cell immunity and antigen-specificity | Hashem Koohy |
| Kini Group - A network approach to identifying novel genes causing neurodevelopmental disorders- The SATB pathway Kini Group - A network approach to identifying novel genes causing neurodevelopmental disorders- The SATB pathway | Usha Kini |
| Chakraverty Group - Design of advanced haematopoietic stem cell and T cell therapies Chakraverty Group - Design of advanced haematopoietic stem cell and T cell therapies | Ronjon Chakraverty |
| Antoniades Group - Cross-talk between adipose tissue and the cardiovascular system in humans: From novel imaging biomarkers development to drug target discovery Antoniades Group - Cross-talk between adipose tissue and the cardiovascular system in humans: From novel imaging biomarkers development to drug target discovery | Charalambos Antoniades |
| Douglas Group - Functional coronary artery disease genetics - defining the function of new causal atherosclerosis genes from CAD GWAS loci using in vitro and in vivo models Douglas Group - Functional coronary artery disease genetics - defining the function of new causal atherosclerosis genes from CAD GWAS loci using in vitro and in vivo models | Gillian Douglas |
| Karpe Group - Human fat distribution and metabolic disease Karpe Group - Human fat distribution and metabolic disease | Fredrik Karpe |
| Cai Group - Cholangiocarcinoma epigenetics for target evaluation Cai Group - Cholangiocarcinoma epigenetics for target evaluation | Shijie Cai |
| Leeson Group - Imaging in Preventive Cardiology Research Leeson Group - Imaging in Preventive Cardiology Research | Paul Leeson |
| Lygate Group - Realising the therapeutic potential of creatine and homoarginine in heart disease Lygate Group - Realising the therapeutic potential of creatine and homoarginine in heart disease | Craig Lygate |
| Piechnik Group - Myocardial functional T1 mapping – Advanced cardiac magnetic resonance imaging techniques Piechnik Group - Myocardial functional T1 mapping – Advanced cardiac magnetic resonance imaging techniques | Stefan Piechnik |
| Reilly Group - Adverse myocardial remodelling in cardiac fibrosis and atrial fibrillation Reilly Group - Adverse myocardial remodelling in cardiac fibrosis and atrial fibrillation | Svetlana Reilly |
| Tzima Group - Go with the flow---the why and how of cardiovascular disease Tzima Group - Go with the flow---the why and how of cardiovascular disease | Ellie Tzima |
| Watkins Group – Creating genetic therapies for inherited heart muscle disease Watkins Group – Creating genetic therapies for inherited heart muscle disease | Hugh Watkins |
| Drakesmith Group - Iron Biology Drakesmith Group - Iron Biology | Hal Drakesmith |
| Goriely Group - De Novo Mutations and Human Disease Goriely Group - De Novo Mutations and Human Disease | Anne Goriely |
| Higgs Group - Laboratory of Gene Regulation Higgs Group - Laboratory of Gene Regulation | Douglas Higgs |
| Mead Group - Unravelling intratumoural heterogeneity in Myeloproliferative Neoplasms Mead Group - Unravelling intratumoural heterogeneity in Myeloproliferative Neoplasms | Adam Mead |
| Twigg/Wilkie Group - Building the skull – normal and abnormal development Twigg/Wilkie Group - Building the skull – normal and abnormal development | Stephen Twigg |
| Nerlov Group - Hematopoietic Stem Cell Genetics Nerlov Group - Hematopoietic Stem Cell Genetics | Claus Nerlov |
| Patel Group - Origins of Genotoxic metabolism and the DNA damage response in stem and cancer cells Patel Group - Origins of Genotoxic metabolism and the DNA damage response in stem and cancer cells | KJ Patel |
| Toepfer Group - Elucidating the role of disease modifying gene variants in inherited cardiomyopathies using induced pluripotent stem cell derived cardiomyocytes and CRISPR/Cas-9. Toepfer Group - Elucidating the role of disease modifying gene variants in inherited cardiomyopathies using induced pluripotent stem cell derived cardiomyocytes and CRISPR/Cas-9. | Christopher Toepfer |
| Christodoulides Group– Deciphering the role of white and brown adipocytes in metabolic disease. Christodoulides Group– Deciphering the role of white and brown adipocytes in metabolic disease. | Constantinos Christodoulides |
| Davis Group - Therapeutic opportunities emerging from studies of immune checkpoints Davis Group - Therapeutic opportunities emerging from studies of immune checkpoints | Simon Davis |
| Chapman Group - Genome Diversification in Cancer and Adaptive Immunity Chapman Group - Genome Diversification in Cancer and Adaptive Immunity | Ross Chapman |
| David Hodson Group - Understanding how glucagon-like peptide-1 (GLP1) and gastric inhibitory polypeptide (GIP) receptors contribute to metabolism in complex tissues David Hodson Group - Understanding how glucagon-like peptide-1 (GLP1) and gastric inhibitory polypeptide (GIP) receptors contribute to metabolism in complex tissues | David Hodson |
| Valkovič Group - Non-invasive cardiac metabolism assessment using ultra-high field (7T) MR Spectroscopy Valkovič Group - Non-invasive cardiac metabolism assessment using ultra-high field (7T) MR Spectroscopy | Ladislav Valkovic |
| Akbar Group - Generating extracellular vesicles for therapeutic Immunomodulation and building tools to determine their diagnostic potential. Akbar Group - Generating extracellular vesicles for therapeutic Immunomodulation and building tools to determine their diagnostic potential. | Naveed Akbar |
| Tyler Group - Imaging Cardiac Metabolism Using Hyperpolarized MRI Tyler Group - Imaging Cardiac Metabolism Using Hyperpolarized MRI | Damian Tyler |